Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Chemotherapy|February 3, 2018
Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer XenograftsHideki Nagase, Fumio Nakagawa, Junji Uchida
Chemotherapy|January 9, 2023
Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal CancerMamoru Nukatsuka, Akio Fujioka, Hideki Nagase, et al.
Thrombosis Research|March 12, 2004
Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregationKenji Kitazato, Keiko T Kitazato, Eiji Sasaki, et al.
Cancer Chemotherapy and Pharmacology|July 4, 2012
Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancerSotaro Sadahiro, Toshiyuki Suzuki, Akira Tanaka, et al.
Biological & Pharmaceutical Bulletin|December 25, 2002
Cell type-dependent divergence of transactivation by glucocorticoid receptor ligandKiyoshi Tanigawa, Katsunao Tanaka, Hideki Nagase, et al.
Journal of Clinical Medicine|December 18, 2020
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation ModelKenta Tsunekuni, Hisato Kawakami, Kazuaki Matsuoka, et al.
Kidney International|March 13, 2003
Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure modelKazuhisa Minamiguchi, Keiko T Kitazato, Hideki Nagase, et al.
International Immunopharmacology|August 22, 2002
Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-estersKiyoshi Tanigawa, Hideki Nagase, Koichi Ohmori, et al.
Anticancer Research|July 31, 2013
Reduction in γ-glutamyl hydrolase expression is associated with response to uracil and tegafur/leucovorin chemotherapy in patients with colorectal cancerSotaro Sadahiro, Toshiyuki Suzuki, Akira Tanaka, et al.
Biochemical and Biophysical Research Communications|September 15, 2007
Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracilEtsuko Sakamoto, Hideki Nagase, Takashi Kobunai, et al.
Pageof 2